Subsidiary of Green Cross Holdings Acquires 1,000 Shares of US Contract Manufacturer for 90 Billion Won

[Asia Economy Reporter Ryu Tae-min] Green Cross Holdings announced on the 19th that its subsidiary COERA will acquire 1,000 shares of BIOCENTRIQ, a US contract manufacturing organization for cell therapy products, for approximately 90 billion KRW. After the acquisition, the ownership stake will be 100%.

Green Cross Holdings stated that the purpose of this stock acquisition is to "enter the US cell therapy CDMO market."

This content was produced with the assistance of AI translation services.